Liquid Biopsies in NSCLC May Prolong Patients' Lives

Patients with ctDNA alterations who received targeted therapy on the basis of these alterations survived longer than patients who did not receive targeted therapy.

Related Keywords

New York ,United States ,Australia ,Sydney ,New South Wales , ,Molecular Diagnostics Service ,Department Of Pathology ,Henryr Kravis Center ,National Institutes Of Health ,Antidote Health Foundation For Cure Of Cancer ,Memorial Sloan Kettering Cancer Center ,New York City ,Antidote Health Foundation ,National Institutes ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Biologic Therapy ,Liquid Biopsy ,Luid Biopsy ,Luid Phase Biopsy ,Cancer Blood Test ,Ancer Saliva Test ,Lood Biopsy ,Erum Biopsy ,Targeted Therapy ,Biopsy ,Tumor ,Genomics ,Genomic Medicine ,Edicine Genomic ,Tissue ,Cancer ,Alignant Neoplasia ,Arcinoma ,Small Cell Lung Cancer ,Match ,Match Day ,Watch Application ,Atch Medical Students ,Dna Sequencing ,Flu ,